MPH Health Care AG Stock
Price
Target price
€19.30
€19.30
-1.000%
-0.2
-1.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
MPH Health Care AG Stock
MPH Health Care AG shows a slight decrease today, losing -€0.200 (-1.000%) compared to yesterday.
Our community identified positive and negative aspects for MPH Health Care AG stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the MPH Health Care AG stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of MPH Health Care AG in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MPH Health Care AG vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
MPH Health Care AG | -1.000% | -0.515% | -19.583% | -42.216% | -13.839% | -6.311% | -37.134% |
Biotest AG ST | -0.930% | -0.465% | 0.943% | 3.382% | 3.382% | 1.182% | 94.545% |
Biotest AG VZ | -3.310% | -0.662% | -0.662% | 14.068% | 9.091% | -16.201% | 45.631% |
Pacira Pharmaceuticals | 0.880% | 2.679% | 5.505% | -12.879% | 24.324% | -60.000% | -44.175% |
News

EQS-News: MPH Health Care AG publishes Annual Report 2024: Further increase in earnings and equity
EQS-News: MPH Health Care AG publishes Annual Report 2024: Further increase in earnings and equity

EQS-News: Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.
EQS-News: Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.